Pursuant to Regulation 29 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, a Meeting of the Warrants Committee of the Company is scheduled to be held on Thursday, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries has informed BSE that a meeting of its Warrants Committee is scheduled for Thursday, 11th June 2026. Under SEBI Listing Regulations, the committee will consider the conversion of warrants into equity shares and the subsequent allotment of those shares. The notice was signed by Sarchit Mehta, Joint Managing Director. No pricing, quantity, or conversion ratio details have been disclosed in this advance notice — those are likely to emerge after the meeting.
This is a standard procedural announcement ahead of a warrants conversion event. It could lead to fresh equity share issuance and potential dilution for existing shareholders once the committee approves the conversion terms.